NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.